---
figid: PMC5796186__ijms-19-00238-g001
figlink: /pmc/articles/PMC5796186/figure/ijms-19-00238-f001/
number: F1
caption: Heterogeneous contributing factors in MPM disease progression. (A) The MPM
  genomic landscape is dominated by frequent gene inactivation in CDKN2A, NF2 and
  BAP1. (B) Several stem cellular signaling pathways, such as Hedgehog (Hh), Wnt/β-catenin,
  Hippo/YAP and Notch have been implicated in MPM pathobiology. (1) Hh ligands (DH,
  IH, and HH) bind patched (PTCH1) to relive inhibition of Smoothened (SMO) and this
  activates the Hh signaling pathway, via transcriptional activation of glioma-associated
  protein (Gli) factors; in the inactive state, Gli3 gets degraded when suppressor
  of fused homolog (Sufu) is inhibited. (2) Protein-serine O-palmitoleoyltransferase
  porcupine (PORCN) is required for efficient binding of Wnt ligands to cell-surface
  Frizzled (Fzd) receptors and to LRP5/6 which signals to the Dishevelled (Dvl) proteins.
  This causes an accumulation of β-catenin in the cytoplasm, followed by nuclear translocation
  and activation of transcription factors. (3) Hippo signaling consists of a cascade
  of kinases, which ultimately phosphorylate and activate serine/threonine-protein
  kinase (LATS)1/2 to inhibit two major downstream effectors of the Hippo pathway—YAP
  and Tafazzin (TAZ)—to stymie signaling (protein degradation). However, in NF2-mutant
  tumors, NAE activates CRL4DCAF1 and thus sustains tumor growth. (4) The Notch pathway
  can be activated by CK2α and when the Notch transmembrane receptors bind to a Notch
  ligand, a cascade of events promote gene transcription via γ secretase. Therapeutics
  (red) to target these pathway components have been developed for Smoothened (Vismodegib),
  Gli (GLI-I, GANT61), PORCN (LGK-974), NAE (MLN-4924) and CK2α (CX-4945 and CIGB-300).
  Arrows indicate interaction or activating effect and T-bars indicate inhibition.
  Green arrows indicate cross-talk between pathways.
pmcid: PMC5796186
papertitle: 'Heterogeneous Contributing Factors in MPM Disease Development and Progression:
  Biological Advances and Clinical Implications.'
reftext: Bhairavi Tolani, et al. Int J Mol Sci. 2018 Jan;19(1):238.
pmc_ranked_result_index: '57320'
pathway_score: 0.8553217
filename: ijms-19-00238-g001.jpg
figtitle: Malignant pleural mesothelioma disease progression
year: '2018'
organisms:
- Homo sapiens
ndex: 5995373e-df20-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5796186__ijms-19-00238-g001.html
  '@type': Dataset
  description: Heterogeneous contributing factors in MPM disease progression. (A)
    The MPM genomic landscape is dominated by frequent gene inactivation in CDKN2A,
    NF2 and BAP1. (B) Several stem cellular signaling pathways, such as Hedgehog (Hh),
    Wnt/β-catenin, Hippo/YAP and Notch have been implicated in MPM pathobiology. (1)
    Hh ligands (DH, IH, and HH) bind patched (PTCH1) to relive inhibition of Smoothened
    (SMO) and this activates the Hh signaling pathway, via transcriptional activation
    of glioma-associated protein (Gli) factors; in the inactive state, Gli3 gets degraded
    when suppressor of fused homolog (Sufu) is inhibited. (2) Protein-serine O-palmitoleoyltransferase
    porcupine (PORCN) is required for efficient binding of Wnt ligands to cell-surface
    Frizzled (Fzd) receptors and to LRP5/6 which signals to the Dishevelled (Dvl)
    proteins. This causes an accumulation of β-catenin in the cytoplasm, followed
    by nuclear translocation and activation of transcription factors. (3) Hippo signaling
    consists of a cascade of kinases, which ultimately phosphorylate and activate
    serine/threonine-protein kinase (LATS)1/2 to inhibit two major downstream effectors
    of the Hippo pathway—YAP and Tafazzin (TAZ)—to stymie signaling (protein degradation).
    However, in NF2-mutant tumors, NAE activates CRL4DCAF1 and thus sustains tumor
    growth. (4) The Notch pathway can be activated by CK2α and when the Notch transmembrane
    receptors bind to a Notch ligand, a cascade of events promote gene transcription
    via γ secretase. Therapeutics (red) to target these pathway components have been
    developed for Smoothened (Vismodegib), Gli (GLI-I, GANT61), PORCN (LGK-974), NAE
    (MLN-4924) and CK2α (CX-4945 and CIGB-300). Arrows indicate interaction or activating
    effect and T-bars indicate inhibition. Green arrows indicate cross-talk between
    pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTNNB1
  - DVL1
  - BAP1
  - AXIN2
  - FZD7
  - FZD8
  - CD44
  - DVL3
  - FAT4
  - FZD9
  - DVL2
  - TAZ
  - CDKN2A
  - FZD10
  - AXIN1
  - CSNK2A2
  - NF2
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - NOTCH1
  - PORCN
  - PTCH1
  - SMO
  - SUFU
  - FZD5
  - CSNK1A1
  - CSNK2A1
  - FZD6
  - WNT9B
  - CSNK2B
  - DCAF1
  - WNT3A
  - WNT7B
  - WNT16
  - WNT4
  - WNT1
  - FZD2
  - IHH
  - WNT11
  - WNT2B
  - WNT9A
  - WNT6
  - WNT7A
  - WNT8A
  - WNT8B
  - WNT10B
  - GLI3
  - GSK3A
  - GSK3B
  - DHH
  - LATS2
  - FZD3
  - FZD1
  - FZD4
  - WNT3
  - WNT5A
  - WNT10A
  - WNT5B
  - SHH
  - YY1AP1
  - WNT2
  - LATS1
  - MLN-4924
  - O
  - Cancer
genes:
- word: B-Catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: BAP1
  symbol: BAP1
  source: hgnc_symbol
  hgnc_symbol: BAP1
  entrez: '8314'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: CD44
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: FAT4
  symbol: FAT4
  source: hgnc_symbol
  hgnc_symbol: FAT4
  entrez: '79633'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: TAZ
  symbol: TAZ
  source: hgnc_symbol
  hgnc_symbol: TAZ
  entrez: '6901'
- word: CDKN2A
  symbol: CDKN2A
  source: hgnc_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: CK2%
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: NF2
  symbol: NF2
  source: hgnc_symbol
  hgnc_symbol: NF2
  entrez: '4771'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: PORCN
  symbol: PORCN
  source: hgnc_symbol
  hgnc_symbol: PORCN
  entrez: '64840'
- word: PTCH1
  symbol: PTCH1
  source: hgnc_symbol
  hgnc_symbol: PTCH1
  entrez: '5727'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: SUFU
  symbol: SUFU
  source: hgnc_symbol
  hgnc_symbol: SUFU
  entrez: '51684'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: CK1
  symbol: CK1
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: CK2%
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: CK2%
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
- word: DCAF1
  symbol: DCAF1
  source: hgnc_symbol
  hgnc_symbol: DCAF1
  entrez: '9730'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: IHH
  entrez: '3549'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: GLI3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: DHH
  entrez: '50846'
- word: LATS1/2
  symbol: LATS2
  source: hgnc_symbol
  hgnc_symbol: LATS2
  entrez: '26524'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Hedgehog
  symbol: Hedgehog
  source: bioentities_symbol
  hgnc_symbol: SHH
  entrez: '6469'
- word: YAP/
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: LATS1/2
  symbol: LATS1
  source: hgnc_symbol
  hgnc_symbol: LATS1
  entrez: '9113'
chemicals:
- word: MLN-4924
  source: MESH
  identifier: C539933
- word: O
  source: MESH
  identifier: D013481
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5796186__F1
redirect_from: /figures/PMC5796186__F1
figtype: Figure
---
